Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

The power of genetics in decoding Sjögren's disease: current status and future development

2 months 1 week ago
Sjögren's disease (SjD) is the second most common systemic autoimmune disease in the United States. SjD patients are predominantly women 30-50 years of age and exhibit heterogeneous clinical manifestations, including symptoms of extensive dryness, chronic fatigue, and joint pain, and various major organ involvement. Late onset, clinical heterogeneity, and limited mechanistic understanding of its etiology frequently lead to delayed or misdiagnosis. Although the etiology of SjD is unclear,...
Marcin Radziszewski

Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)

2 months 1 week ago
EAI141 was a prospective, multi-center trial designed to assess 3'-deoxy-3'-^(18)F-fluorothymidine (FLT) PET/CT as a treatment response biomarker. The primary objective was to evaluate the negative predictive value (NPV) of post-treatment 'day 14' FLT-uptake (clinically non-responding patients with high FLT uptake). Among 87 patients enrolled from 9 centers, 61 were evaluable for the primary endpoint. The NPV for FLT PET/CT was 0.20 (3/15, 95% CI 0.04-0.48) compared to the NPV for nadir bone...
Robert Jeraj

PFKFB2 Is Pivotal for Metabolic Flexibility and Differential Glucose Utilization

2 months 1 week ago
CONCLUSIONS: PFKFB2 is essential for fed-to-fasted changes in cardiac metabolism and plays an important regulatory role in protein O-GlcNAcylation. Its loss also affects systemic glucose homeostasis under stressed conditions.
Kylene M Harold

Latent Classes in Long-Term Functional Status in Children With Recurrent Critical Illness

2 months 1 week ago
CONCLUSIONS: In this multi-institutional database study using FSS scores to describe a contemporary, heterogeneous patient population with recurrent PICU-based observations of functional status, we identified six classes of outcome trajectories with different clinical and demographic characteristics.
Julia A Heneghan

Socially responsive yolk steroids correlate with gene expression in early extra-embryonic membranes

2 months 1 week ago
Females communicate non-genetic information about the environment to their developing offspring to generate potentially adaptive phenotypic variation. For example, birds allocate steroid hormones to their egg yolks in response to social stimuli and these hormones can induce long-lasting changes to offspring physiology and behavior. However, little work has explored how multiple yolk steroids respond to social challenges, despite their shared biosynthetic pathway, or how they impact early...
Jasmeen Kaur

Pagination

  • Previous page ‹ Previous
  • Page 55
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies